Report Detail
Global (United States, European Union and China) Chronic Urticaria Or Hives Drug Market Research Report 2019-2025
- RnM3370501 |
- 01 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Chronic Urticaria Or Hives Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Chronic Urticaria Or Hives Drug.
This report studies the global market size of Chronic Urticaria Or Hives Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Chronic Urticaria Or Hives Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Market Segment by Product Type
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Market Segment by Application
Clinic
Hospital
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Chronic Urticaria Or Hives Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Chronic Urticaria Or Hives Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Chronic Urticaria Or Hives Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 GDC-0853
- 1.3.3 GSK-2646264
- 1.3.4 BF-Derm-1
- 1.3.5 Bilastine
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Chronic Urticaria Or Hives Drug Market Share by Application (2019-2025)
- 1.4.2 Clinic
- 1.4.3 Hospital
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Chronic Urticaria Or Hives Drug Market Size
- 2.1.1 Global Chronic Urticaria Or Hives Drug Revenue 2014-2025
- 2.1.2 Global Chronic Urticaria Or Hives Drug Sales 2014-2025
- 2.2 Chronic Urticaria Or Hives Drug Growth Rate by Regions
- 2.2.1 Global Chronic Urticaria Or Hives Drug Sales by Regions 2014-2019
- 2.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers
- 3.1.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers 2014-2019
- 3.1.2 Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Chronic Urticaria Or Hives Drug Price by Manufacturers
- 3.4 Key Manufacturers Chronic Urticaria Or Hives Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
- 3.6 Key Manufacturers Chronic Urticaria Or Hives Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 GDC-0853 Sales and Revenue (2014-2019)
- 4.1.2 GSK-2646264 Sales and Revenue (2014-2019)
- 4.1.3 BF-Derm-1 Sales and Revenue (2014-2019)
- 4.1.4 Bilastine Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type
- 4.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type
- 4.4 Chronic Urticaria Or Hives Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Chronic Urticaria Or Hives Drug Sales by Application
6 United States
- 6.1 United States Chronic Urticaria Or Hives Drug Breakdown Data by Company
- 6.2 United States Chronic Urticaria Or Hives Drug Breakdown Data by Type
- 6.3 United States Chronic Urticaria Or Hives Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Chronic Urticaria Or Hives Drug Breakdown Data by Company
- 7.2 European Union Chronic Urticaria Or Hives Drug Breakdown Data by Type
- 7.3 European Union Chronic Urticaria Or Hives Drug Breakdown Data by Application
8 China
- 8.1 China Chronic Urticaria Or Hives Drug Breakdown Data by Company
- 8.2 China Chronic Urticaria Or Hives Drug Breakdown Data by Type
- 8.3 China Chronic Urticaria Or Hives Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Chronic Urticaria Or Hives Drug Breakdown Data by Company
- 9.2 Rest of World Chronic Urticaria Or Hives Drug Breakdown Data by Type
- 9.3 Rest of World Chronic Urticaria Or Hives Drug Breakdown Data by Application
- 9.4 Rest of World Chronic Urticaria Or Hives Drug Breakdown Data by Countries
- 9.4.1 Rest of World Chronic Urticaria Or Hives Drug Sales by Countries
- 9.4.2 Rest of World Chronic Urticaria Or Hives Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AstraZeneca Plc
- 10.1.1 AstraZeneca Plc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.1.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.1.5 AstraZeneca Plc Recent Development
- 10.2 Biofrontera AG
- 10.2.1 Biofrontera AG Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.2.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.2.5 Biofrontera AG Recent Development
- 10.3 ELORAC, Inc.
- 10.3.1 ELORAC, Inc. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.3.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.3.5 ELORAC, Inc. Recent Development
- 10.4 Faes Farma, SA
- 10.4.1 Faes Farma, SA Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.4.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.4.5 Faes Farma, SA Recent Development
- 10.5 Genentech, Inc.
- 10.5.1 Genentech, Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.5.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.5.5 Genentech, Inc. Recent Development
- 10.6 GlaxoSmithKline Plc
- 10.6.1 GlaxoSmithKline Plc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.6.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.6.5 GlaxoSmithKline Plc Recent Development
- 10.7 J Uriach Y Compania, S.A.
- 10.7.1 J Uriach Y Compania, S.A. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.7.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.7.5 J Uriach Y Compania, S.A. Recent Development
- 10.8 Mabtech Limited
- 10.8.1 Mabtech Limited Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.8.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.8.5 Mabtech Limited Recent Development
- 10.9 Merck & Co., Inc.
- 10.9.1 Merck & Co., Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.9.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.9.5 Merck & Co., Inc. Recent Development
- 10.10 Mycenax Biotech Inc.
- 10.10.1 Mycenax Biotech Inc. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Chronic Urticaria Or Hives Drug
- 10.10.4 Chronic Urticaria Or Hives Drug Product Introduction
- 10.10.5 Mycenax Biotech Inc. Recent Development
- 10.11 Novartis AG
- 10.12 Panacea Biotec Limited
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Chronic Urticaria Or Hives Drug Sales Channels
- 11.2.2 Chronic Urticaria Or Hives Drug Distributors
- 11.3 Chronic Urticaria Or Hives Drug Customers
12 Market Forecast
- 12.1 Global Chronic Urticaria Or Hives Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Chronic Urticaria Or Hives Drug Sales Forecast by Type
- 12.3 Global Chronic Urticaria Or Hives Drug Sales Forecast by Application
- 12.4 Chronic Urticaria Or Hives Drug Forecast by Regions
- 12.4.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Chronic Urticaria Or Hives Drug . Industry analysis & Market Report on Chronic Urticaria Or Hives Drug is a syndicated market report, published as Global (United States, European Union and China) Chronic Urticaria Or Hives Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Chronic Urticaria Or Hives Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
